Cargando…
The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
The sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of antidiabetic drugs that, in addition to emerging as an effective hypoglycemic treatment, have been shown to improve, in several trials, both renal and cardiovascular outcomes. In consideration of the renal site of a...
Autores principales: | Cianciolo, Giuseppe, De Pascalis, Antonio, Gasperoni, Lorenzo, Tondolo, Francesco, Zappulo, Fulvia, Capelli, Irene, Cappuccilli, Maria, La Manna, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355461/ https://www.ncbi.nlm.nih.gov/pubmed/32549243 http://dx.doi.org/10.3390/molecules25122757 |
Ejemplares similares
-
Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019) -
Folic Acid and Vitamin B12 Administration in CKD, Why Not?
por: Capelli, Irene, et al.
Publicado: (2019) -
Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients
por: Cianciolo, Giuseppe, et al.
Publicado: (2021) -
Vitamin D and the Kidney: Two Players, One Console
por: Zappulo, Fulvia, et al.
Publicado: (2022) -
Toxin Removal and Inflammatory State Modulation during Online Hemodiafiltration Using Two Different Dialyzers (TRIAD2 Study)
por: Donati, Gabriele, et al.
Publicado: (2021)